Aurentz Vincent serves as Executive at EPIRUS Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Aurentz Vincent has executed 2 insider transactions totaling $18.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 17, 2015 involved purchasing 2,200 shares valued at $7.5K.
Aurentz Vincent currently holds 2,200 shares of EPIRUS Biopharmaceuticals, Inc. (EPRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aurentz Vincent has been a net buyer of EPRS stock. They have purchased $18.3K and sold $0 worth of shares.
Aurentz Vincent's most recent insider trade was on Dec 17, 2015, when they purchased 2,200 shares at $3.43 per share.
Get notified when new Form 4 filings are submitted
| $3.85 |
| Discretionary |